The intersection of substance use with broader public health concerns.
Public Health
New Psychoactive Substances: What Are Synthetic Cannabinoids, Their Mechanisms of Action, and Health Risks?
Thursday, July 7, 2022 10:00 AM Eastern Time (Washington, DC time)
The presenters will discuss synthetic cannabinoids' action mechanisms and health risks in this webinar. Spanish - English interpretation will be available. No certificates of attendance will be offered.
Presenters
Highlights from the 2022 UNODC World Drug Report: Implications for drug prevention, treatment and care responses
ISSUP presented a webinar on Thursday, July 7, 2022, featuring Giovanna Campello, Chief of the Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC) presenting highlights from the 2022 edition of...
The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis
Comorbid mental illnesses and substance use disorders are associated with adverse criminal, social, and health outcomes. Yet, their burden is not reliably known among prison populations. We therefore aimed to estimate the prevalence of comorbid serious mental illnesses and substance use disorders (dual disorders) among people in prison worldwide.
New Psychoactive Substances (NPS): Black market and policy of new psychoactive substances in the Asia region
ISSUP Kazakhstan presented the Third Webinar in the Series on New Psychoactive Substances, with a focus on Black market and policy of new psychoactive substances in the Asia region.
New Psychoactive Substances (NPS): Black market and policy of new psychoactive substances in the Asia region
ISSUP Kazakhstan presented the Third Webinar in the Series on New Psychoactive Substances, with a focus on Black market and policy of new psychoactive substances in the Asia region.
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances
This document provides guidance on the clinical management of harms resulting from acute intoxication and from the harmful and dependent use of club drugs and Novel Psychoactive Substances (NPS). This is an extensive and comprehensive...
Risks, harms and clinical implications of Novel Psychoactive Substances
As part for the new webinar series of International Society for the Study of Emerging Drugs (ISSED), we are pleased to invite you to attend a workshop on “Health Risks, Harms and Clinical Implications of Novel Psychoactive Substances” facilitated by Prof. Giuseppe Bersani and Prof. Owen Bowden-Jones.
Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS
Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the...
Novel Psychoactive Substances: Policy, Economics and Drug Regulation
In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it...
